Core Viewpoint - The company, 信铭生命科技 (Ximing Life Science Technology), is set to hold a board meeting on November 28, 2025, to approve its unaudited interim results for the six months ending September 30, 2025, and to consider the distribution of an interim dividend if applicable [1] Summary by Categories - Board Meeting Details - The board meeting will take place at 11:00 AM on November 28, 2025, at the 瑞安中心 (Rui'an Center) in Wan Chai, Hong Kong [1] - Financial Performance Review - The meeting will include the approval of the company's unaudited interim results for the six months ending September 30, 2025 [1] - Dividend Consideration - The board will also consider the distribution of an interim dividend, subject to availability [1]
信铭生命科技(00474.HK)拟11月28日举行董事会会议审批中期业绩